GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Relatlimab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Metastatic Melanoma.

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

LAG-3 drugs from arch-rivals Bristol-Myers Squibb ... with results showing a single infusion of its LAG-3 blocker relatlimab and its Opdivo immunotherapy improved progression-free survival in ...

The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...

That has meant turning from tracking infections to tracking illicit and high-risk drug use. Monitoring wastewater for viruses works because infected people excrete tiny bits of viral matter ...

Members of my lab are interested in how hormones act in the brain to influence response to drugs of abuse. This student was engaged in primarily archival research on this topic. During her time ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. In the ...

One of the doctors charged in the drug-related death of actor Matthew Perry last year has appeared in a US court. Mark Chavez was bailed at the hearing in Los Angeles on Friday during which he ...

AMSTERDAM—Organized crime used to be considered a remote threat in much of Western Europe, but ruthless violence by criminal gangs is now rattling the peace in some of the world’s safest ...

The global drug trade exhibits striking regional differences, with varying drug preferences across different parts of the world. However, a common thread unites these regions: The pervasive rise ...